Contract 75D30125D20476
Bavarian Nordic, Inc. · Department Of Health And Human Services · August 20, 2025
Bavarian Nordic, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 20, 2025 for $320,000 of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 11, 2026. If all options are exercised, the contract could reach $9.43 million.
Contract details
- PIID
- 75D30125D20476
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 20, 2025
- Latest action
- March 11, 2026
Description
ADULT VACCINES
Modification timeline
-
March 11, 2026Mod P00004 · Funding Only Action$339.5K
-
January 21, 2026Mod P00003 · Funding Only Action$236.8K
-
December 11, 2025Mod P00002 · Other Administrative Action$236.8K
-
August 20, 2025Mod P00001 · Funding Only Action$236.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30125D20476?
Contract 75D30125D20476 is a federal contract awarded to Bavarian Nordic, Inc. by Department Of Health And Human Services on August 20, 2025 for $320,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 75D30125D20476?
Bavarian Nordic, Inc. won contract 75D30125D20476 from Department Of Health And Human Services.
How much is contract 75D30125D20476 worth?
Contract 75D30125D20476 has obligated $320,000 to date, with a total potential value of $9.43 million if all options are exercised.